Trial Profile
Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Delgocitinib (Primary) ; Delgocitinib (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 30 May 2018 Status changed from recruiting to discontinued.
- 01 Nov 2017 Status changed from not yet recruiting to recruiting.
- 01 Nov 2017 New trial record